Physician profile
William Bennett
NPI 1073519047
$2,903.08
in general payments reported to CMS, 2019-2025
33 companies · $792 in 2025
The $792 reported for 2025 was more than what 76% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2021: $149 · 2022: $502 · 2023: $565 · 2024: $526 · 2025: $792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $504.78 | 2019-2024 | Citrefix, Augment Injectable, Infinity |
| Treace Medical Concepts, INC. | $251.22 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $219.31 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $196.16 | 2019-2025 | Stravix, Grafix Pl, Stravix Pl |
| Integra Lifesciences Corporation | $167.01 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $144.28 | 2022 | |
| Bioventus LLC | $135.02 | 2024 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $132.90 | 2019-2022 | |
| Mimedx Group, INC. | $128.42 | 2024-2025 | |
| Kci USA, INC. | $117.18 | 2019-2023 | Activ.A.C., Promogran Prisma |
| Depuy Synthes Sales INC. | $91.96 | 2023-2025 | Minibunion, Motoband |
| Kerecis Limited | $71.87 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $69.93 | 2019 | |
| Paragon 28, INC. | $63.38 | 2025 | Avitus Bone Graft Harvester, Portfolio |
| Acera Surgical, INC. | $60.40 | 2023-2025 | Restrata Wound Matrix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $56.64 | 2023-2024 | |
| Arthrosurface Incorporated | $54.95 | 2019 | |
| Osiris Therapeutics INC. | $48.50 | 2019 | |
| Orthofix Medical, INC. | $47.13 | 2022-2024 | Physio-Stim |
| Tactile Systems Technology INC | $42.48 | 2019-2025 | Nimbl, Flexitouch Plus |
| Nevro Corp. | $36.77 | 2023-2024 | Senza |
| Averitas Pharma INC. | $31.84 | 2025 | Qutenza |
| Convatec INC. | $31.53 | 2023 | |
| Ets Wound Care LLC | $30.36 | 2025 | Mirragen Advanced Wound Matrix |
| Next Science LLC | $27.06 | 2023 | Xperience, Blastx, Surgx |
| Amgen INC. | $25.04 | 2024 | Krystexxa |
| Acumed LLC | $21.89 | 2024 | Osteomed |
| Ibsa Pharma INC. | $21.15 | 2023 | Tirosint, Licart |
| Melinta Therapeutics, LLC | $18.30 | 2019 | |
| Polynovo North America LLC | $15.65 | 2025 | Novosorb Btm |
| Cashflow Solutions, LLC | $14.61 | 2024 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Dentsply Sirona INC | $14.27 | 2025 | Prime&Bond Nt Nano-Technology Light Cured Dental Adhesive |
| Wright Medical Technology, INC. | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.